— Know what they know.
Not Investment Advice

ADPT NASDAQ

Adaptive Biotechnologies Corporation
1W: +5.2% 1M: -2.3% 3M: -8.8% YTD: -12.8% 1Y: +48.2% 3Y: +123.7% 5Y: -59.8%
$13.88
+0.01 (+0.07%)
 
Weekly Expected Move ±6.5%
$11 $12 $13 $14 $14
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 47 · $2.2B mcap · 154M float · 1.25% daily turnover · Short 33% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
52.9 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -13.6%  ·  5Y Avg: -89.8%
Cost Advantage
54
Intangibles
44
Switching Cost
62
Network Effect
82
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ADPT shows a Weak competitive edge (52.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. Negative ROIC of -13.6% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$21
Avg Target
$21
High
Based on 6 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 11Hold: 4Sell: 2Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$20.83
Analysts6
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-02-06 BTIG $5 $22 +17 +33.6% $16.47
2026-02-06 Piper Sandler Sebastian Sandler $20 $21 +1 +27.5% $16.47
2026-01-26 Guggenheim $20 $21 +1 +11.1% $18.91
2025-12-01 Morgan Stanley Kallum Titchmarsh $18 $21 +3 +11.5% $18.84
2025-10-15 Piper Sandler $14 $20 +6 +22.9% $16.28
2025-09-30 Guggenheim Initiated $20 +48.6% $13.46
2024-04-04 BTIG Mark Massaro Initiated $5 +86.6% $2.68
2022-12-20 Piper Sandler David Westenberg $12 $14 +2 +97.5% $7.09
2022-08-17 Piper Sandler David Westenberg $8 $12 +4 +3.9% $11.55
2022-06-13 Piper Sandler David Westenberg Initiated $8 +7.6% $6.97
2022-05-06 Morgan Stanley Initiated $18 +120.9% $8.15

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ADPT receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

35 Grade D
Profitability
20
Balance Sheet
55
Earnings Quality
57
Growth
88
Value
27
Momentum
80
Safety
30
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ADPT scores highest in Growth (88/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.60
Distress Zone
Piotroski F-Score
5/9
Beneish M-Score
-2.55
Unlikely Manipulator
Ohlson O-Score
-6.23
Bankruptcy prob: 0.2%
Low Risk
Credit Rating
BB-
Score: 37.9/100
Trend: Improving
Earnings Quality
OCF/NI: 0.54x
Accruals: -4.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ADPT scores 1.60, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ADPT scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ADPT's score of -2.55 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ADPT's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ADPT receives an estimated rating of BB- (score: 37.9/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-43.45x
PEG
-0.34x
P/S
7.52x
P/B
9.98x
P/FCF
-73.09x
P/OCF
EV/EBITDA
-100.42x
EV/Revenue
7.49x
EV/EBIT
-56.77x
EV/FCF
-74.90x
Earnings Yield
-2.30%
FCF Yield
-1.37%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ADPT currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.274
EBT / EBIT
×
EBIT Margin
-0.132
EBIT / Rev
×
Asset Turnover
0.562
Rev / Assets
×
Equity Multiplier
2.496
Assets / Equity
=
ROE
-23.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ADPT's ROE of -23.6% is driven by Asset Turnover (0.562), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1736 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$13.88
Median 1Y
$8.96
5th Pctile
$2.61
95th Pctile
$30.83
Ann. Volatility
75.7%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Chad Robins
Chief Executive Officer and Chairman
$698,258 $7,675,100 $9,081,690
Harlan Robins, PhD
Chief Scientific Officer
$558,653 $7,675,100 $8,509,575
Julie Rubinstein Operating
and Chief Operating Officer
$542,383 $3,783,500 $4,603,995
Susan Bobulsky Commercial
ercial Officer, MRD
$435,750 $1,883,990 $3,547,558
Kyle Piskel Financial
ancial Officer
$399,950 $2,702,500 $3,310,729

CEO Pay Ratio

34:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $9,081,690
Avg Employee Cost (SGA/emp): $268,064
Employees: 624

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
624
+0.8% YoY
Revenue / Employee
$443,872
Rev: $276,976,000
Profit / Employee
$-95,351
NI: $-59,499,000
SGA / Employee
$268,064
Avg labor cost proxy
R&D / Employee
$150,271
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -26.1% -29.0% -30.8% -34.0% -34.5% -32.9% -37.5% -36.5% -35.7% -36.7% -58.3% -55.7% -55.3% -50.5% -62.4% -55.5% -47.4% -31.2% -28.2% -23.6% -23.57%
ROA -16.9% -18.8% -20.3% -22.5% -22.8% -21.7% -22.5% -21.9% -21.5% -22.0% -29.7% -28.3% -28.1% -25.7% -26.6% -23.6% -20.2% -13.3% -11.3% -9.4% -9.44%
ROIC -83.6% -92.9% -45.5% -50.3% -50.9% -48.5% -2.1% -2.1% -2.0% -2.1% -3.0% -2.8% -2.8% -2.6% -1.8% -1.6% -1.4% -88.5% -16.6% -13.6% -13.55%
ROCE -17.0% -18.9% -25.8% -28.4% -28.7% -27.3% -26.3% -25.1% -24.1% -24.3% -36.9% -35.2% -35.1% -32.1% -33.5% -30.9% -26.1% -16.7% -12.7% -9.2% -9.22%
Gross Margin 72.0% 64.0% 62.2% 65.8% 69.7% 68.8% 69.9% 50.4% 63.4% 49.0% 57.2% 56.9% 55.3% 64.1% 62.0% 67.6% 69.4% 80.7% 74.6% 73.6% 73.60%
Operating Margin -1.3% -1.4% -1.6% -1.6% -1.2% -95.0% -71.0% -1.5% -97.7% -1.3% -1.6% -1.2% -1.1% -70.3% -71.3% -56.4% -42.5% 10.9% -17.8% -27.1% -27.10%
Net Margin -1.3% -1.4% -1.6% -1.6% -1.2% -94.7% -72.7% -1.5% -97.7% -1.3% -1.5% -1.1% -1.1% -69.1% -71.0% -56.9% -43.5% 10.2% -18.9% -28.3% -28.27%
EBITDA Margin -1.2% -1.3% -1.5% -1.5% -1.1% -82.1% -56.7% -1.3% -75.1% -1.1% -1.3% -93.9% -89.3% -52.9% -55.5% -56.4% -30.8% 18.0% -9.0% -20.3% -20.29%
FCF Margin -1.8% -1.6% -1.6% -1.6% -1.5% -1.4% -1.1% -1.1% -89.5% -95.4% -98.1% -83.0% -80.9% -64.6% -55.3% -46.8% -40.4% -24.9% -17.7% -10.0% -10.00%
OCF Margin -1.4% -1.2% -1.2% -1.3% -1.3% -1.2% -99.3% -96.9% -81.8% -88.7% -91.8% -77.7% -76.6% -61.9% -53.2% -45.0% -39.2% -23.9% -16.6% -9.2% -9.15%
ROE 3Y Avg snapshot only -54.14%
ROE 5Y Avg snapshot only -48.49%
ROA 3Y Avg snapshot only -22.84%
ROIC 3Y Avg snapshot only -91.80%
ROIC Economic snapshot only -7.48%
Cash ROA snapshot only -5.27%
Cash ROIC snapshot only -9.93%
CROIC snapshot only -10.84%
NOPAT Margin snapshot only -12.50%
Pretax Margin snapshot only -16.81%
R&D / Revenue snapshot only 31.55%
SGA / Revenue snapshot only 58.95%
SBC / Revenue snapshot only 12.87%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -33.49 -25.14 -19.13 -8.58 -4.96 -4.60 -5.46 -6.49 -5.07 -4.02 -3.15 -2.18 -2.50 -3.87 -5.53 -7.82 -14.61 -30.66 -41.80 -43.45 -43.451
P/S Ratio 42.98 32.65 25.68 12.73 7.21 6.06 5.90 6.87 5.11 4.39 4.17 2.68 3.16 4.26 4.93 5.85 8.63 9.66 8.98 7.31 7.520
P/B Ratio 7.72 6.44 6.56 3.26 1.91 1.68 2.35 2.73 2.09 1.70 2.30 1.52 1.73 2.45 4.35 5.47 8.74 12.04 11.37 9.87 9.978
P/FCF -24.52 -19.89 -15.57 -7.93 -4.78 -4.41 -5.46 -6.50 -5.71 -4.60 -4.25 -3.23 -3.91 -6.59 -8.93 -12.49 -21.40 -38.78 -50.81 -73.09 -73.087
P/OCF
EV/EBITDA -31.40 -23.14 -19.12 -8.07 -4.26 -3.87 -4.01 -5.28 -3.71 -2.53 -2.47 -1.24 -1.59 -3.10 -5.82 -8.20 -16.62 -40.39 -68.19 -100.42 -100.419
EV/Revenue 38.63 28.69 24.11 11.17 5.70 4.62 3.79 4.76 3.05 2.22 2.72 1.26 1.69 2.86 4.19 5.15 7.99 9.13 9.17 7.49 7.489
EV/EBIT -29.91 -21.99 -17.84 -7.50 -3.92 -3.51 -3.58 -4.68 -3.22 -2.19 -2.19 -1.09 -1.42 -2.76 -5.07 -7.16 -14.21 -31.34 -47.48 -56.77 -56.769
EV/FCF -22.04 -17.48 -14.62 -6.96 -3.78 -3.36 -3.51 -4.50 -3.41 -2.33 -2.77 -1.52 -2.09 -4.43 -7.58 -10.99 -19.79 -36.67 -51.90 -74.90 -74.902
Earnings Yield -3.0% -4.0% -5.2% -11.7% -20.2% -21.8% -18.3% -15.4% -19.7% -24.8% -31.7% -46.0% -40.0% -25.9% -18.1% -12.8% -6.8% -3.3% -2.4% -2.3% -2.30%
FCF Yield -4.1% -5.0% -6.4% -12.6% -20.9% -22.7% -18.3% -15.4% -17.5% -21.7% -23.5% -30.9% -25.6% -15.2% -11.2% -8.0% -4.7% -2.6% -2.0% -1.4% -1.37%
Price/Tangible Book snapshot only 22.006
EV/Gross Profit snapshot only 9.951
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 6.91 6.91 3.54 3.54 3.54 3.54 5.12 5.12 5.12 5.12 4.66 4.66 4.66 4.66 2.89 2.89 2.89 2.89 3.34 3.34 3.339
Quick Ratio 6.78 6.78 3.37 3.37 3.37 3.37 4.99 4.99 4.99 4.99 4.50 4.50 4.50 4.50 2.81 2.81 2.81 2.81 3.23 3.23 3.229
Debt/Equity 0.15 0.15 0.19 0.19 0.19 0.19 0.23 0.23 0.23 0.23 0.32 0.32 0.32 0.32 0.44 0.44 0.44 0.44 1.28 1.28 1.282
Net Debt/Equity -0.78 -0.78 -0.40 -0.40 -0.40 -0.40 -0.84 -0.84 -0.84 -0.84 -0.80 -0.80 -0.80 -0.80 -0.66 -0.66 -0.66 -0.66 0.24 0.24 0.245
Debt/Assets 0.10 0.10 0.12 0.12 0.12 0.12 0.13 0.13 0.13 0.13 0.15 0.15 0.15 0.15 0.17 0.17 0.17 0.17 0.55 0.55 0.547
Debt/EBITDA -0.66 -0.59 -0.57 -0.52 -0.52 -0.56 -0.62 -0.65 -0.69 -0.68 -0.53 -0.55 -0.55 -0.60 -0.69 -0.75 -0.91 -1.56 -7.53 -12.74 -12.736
Net Debt/EBITDA 3.54 3.19 1.24 1.13 1.13 1.20 2.23 2.35 2.50 2.47 1.32 1.39 1.38 1.51 1.03 1.12 1.35 2.33 -1.44 -2.43 -2.433
Interest Coverage -338.66 -46.28 -24.13 -15.79 -12.64 -15.33 -15.22 -16.29 -15.78 -12.78 -11.85 -9.82 -6.25 -4.54 -3.31 -3.313
Equity Multiplier 1.50 1.50 1.53 1.53 1.53 1.53 1.85 1.85 1.85 1.85 2.14 2.14 2.14 2.14 2.66 2.66 2.66 2.66 2.34 2.34 2.343
Cash Ratio snapshot only 2.524
Debt Service Coverage snapshot only -1.873
Cash to Debt snapshot only 0.809
FCF to Debt snapshot only -0.105
Defensive Interval snapshot only 376.3 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.13 0.14 0.15 0.15 0.16 0.16 0.21 0.21 0.21 0.20 0.22 0.23 0.22 0.23 0.30 0.32 0.34 0.42 0.53 0.56 0.562
Inventory Turnover 2.86 3.56 2.96 3.15 3.30 3.34 3.44 3.76 4.04 4.30 5.23 5.18 5.28 5.10 6.30 6.20 6.09 6.22 7.82 8.01 8.005
Receivables Turnover 11.74 12.90 11.24 11.26 11.63 12.24 6.45 6.42 6.60 6.25 4.36 4.47 4.33 4.54 4.49 4.76 5.15 6.34 6.01 6.42 6.415
Payables Turnover 8.59 10.71 15.07 16.05 16.80 17.02 10.17 11.13 11.95 12.73 9.56 9.48 9.66 9.32 9.62 9.48 9.30 9.50 10.39 10.64 10.645
DSO 31 28 32 32 31 30 57 57 55 58 84 82 84 80 81 77 71 58 61 57 56.9 days
DIO 128 103 123 116 111 109 106 97 90 85 70 70 69 72 58 59 60 59 47 46 45.6 days
DPO 42 34 24 23 22 21 36 33 31 29 38 38 38 39 38 39 39 38 35 34 34.3 days
Cash Conversion Cycle 116 97 132 126 120 118 127 121 115 115 115 114 116 113 101 97 92 78 72 68 68.2 days
Fixed Asset Turnover snapshot only 3.953
Operating Cycle snapshot only 102.5 days
Cash Velocity snapshot only 1.301
Capital Intensity snapshot only 1.736
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 44.8% 58.6% 56.9% 33.3% 19.7% 14.6% 20.1% 19.3% 18.7% 6.9% -8.1% -5.3% -11.0% -1.3% 5.1% 8.6% 21.6% 42.6% 54.8% 55.9% 55.87%
Net Income -72.1% -55.7% -41.7% -47.5% -35.5% -16.3% 3.3% 14.9% 17.7% 11.5% -12.5% -10.2% -11.8% 0.4% 29.2% 34.0% 43.2% 59.2% 62.7% 65.0% 64.97%
EPS -56.2% -48.6% -37.4% -44.7% -33.6% -14.6% 4.6% 16.0% 18.9% 12.6% -11.1% -8.5% -9.5% 2.3% 30.3% 35.6% 45.0% 63.1% 64.2% 66.4% 66.40%
FCF -79.0% -62.1% -51.0% -19.2% -3.0% 4.1% 21.3% 21.4% 29.6% 25.8% 16.6% 25.7% 19.5% 33.2% 40.8% 38.7% 39.4% 45.1% 50.5% 66.7% 66.72%
EBITDA -55.4% -45.9% -33.1% -40.5% -30.2% -10.4% 10.0% 22.3% 27.0% 21.4% -7.0% -7.1% -15.3% -3.7% 31.3% 33.1% 45.2% 65.1% 71.1% 81.5% 81.49%
Op. Income -51.5% -44.3% -36.7% -44.7% -35.5% -16.2% 4.2% 15.8% 18.8% 12.3% -13.4% -12.5% -15.0% -2.4% 28.4% 34.4% 44.5% 60.9% 64.9% 67.4% 67.41%
OCF Growth snapshot only 68.32%
Asset Growth snapshot only -4.94%
Equity Growth snapshot only 7.93%
Debt Growth snapshot only 2.14%
Shares Change snapshot only 4.24%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 93.2% 51.6% 36.8% 25.5% 27.2% 24.8% 20.1% 14.6% 8.1% 6.5% 5.1% 7.0% 8.7% 14.6% 14.3% 17.0% 17.02%
Revenue 5Y 50.1% 29.8% 19.8% 15.2% 17.4% 22.3% 23.0% 20.6% 20.57%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 85.5% 45.0% 32.2% 19.6% 20.0% 15.2% 7.7% 3.9% -2.7% -0.6% 0.6% 5.1% 9.0% 17.3% 17.3% 22.5% 22.50%
Gross Profit 5Y 41.3% 23.0% 14.2% 10.9% 14.0% 21.0% 22.1% 20.2% 20.16%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 40.5% 40.5% -2.1% -2.1% -2.1% -2.1% -16.0% -16.0% -16.0% -16.0% -16.4% -16.4% -16.4% -16.4% -15.7% -15.7% -15.72%
Assets 5Y 14.7% 14.7% -10.0% -10.0% -10.0% -10.0% -14.4% -14.4% -14.41%
Equity 3Y -6.7% -6.7% -6.7% -6.7% -25.4% -25.4% -25.4% -25.4% -30.5% -30.5% -30.5% -30.5% -22.2% -22.2% -22.17%
Book Value 3Y -10.9% -10.6% -10.5% -9.0% -26.8% -26.6% -26.6% -26.6% -31.4% -31.7% -32.0% -33.5% -23.9% -24.2% -24.23%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.98 1.00 0.96 0.98 0.95 0.97 0.98 0.99 0.99 0.89 0.70 0.77 0.83 0.83 0.76 0.85 0.84 0.88 0.79 0.78 0.777
Earnings Stability 1.00 0.99 0.98 1.00 0.99 0.96 0.83 0.71 0.80 0.77 0.81 0.67 0.75 0.65 0.43 0.19 0.04 0.05 0.24 0.40 0.396
Margin Stability 0.99 0.97 0.93 0.92 0.93 0.94 0.93 0.92 0.91 0.90 0.87 0.88 0.88 0.88 0.88 0.90 0.88 0.89 0.86 0.88 0.876
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.83 0.81 0.86 0.93 0.99 0.94 0.93 0.95 0.95 0.96 0.95 1.00 0.88 0.86 0.83 0.50 0.50 0.50 0.500
Earnings Smoothness
ROE Trend -0.20 -0.20 -0.18 -0.13 -0.16 -0.13 -0.10 -0.11 -0.34 -0.30 -0.29 -0.24 -0.21 -0.14 -0.05 0.13 0.49 0.47 0.471
Gross Margin Trend 0.00 -0.04 -0.09 -0.10 -0.10 -0.07 -0.04 -0.06 -0.06 -0.10 -0.13 -0.09 -0.10 -0.05 -0.02 0.01 0.07 0.13 0.17 0.15 0.155
FCF Margin Trend -0.65 -0.31 -0.24 -0.09 0.08 0.25 0.60 0.64 0.74 0.55 0.38 0.50 0.39 0.52 0.48 0.48 0.45 0.55 0.59 0.55 0.549
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.07 0.94 0.93 0.87 0.90 0.94 0.92 0.92 0.81 0.81 0.69 0.63 0.61 0.56 0.60 0.60 0.66 0.76 0.77 0.54 0.544
FCF/OCF 1.28 1.35 1.32 1.25 1.15 1.11 1.09 1.09 1.09 1.07 1.07 1.07 1.06 1.04 1.04 1.04 1.03 1.04 1.06 1.09 1.092
FCF/Net Income snapshot only 0.595
CapEx/Revenue 38.6% 42.2% 40.0% 31.7% 20.2% 13.7% 8.8% 8.8% 7.7% 6.6% 6.3% 5.3% 4.3% 2.8% 2.0% 1.8% 1.1% 1.0% 1.1% 0.8% 0.84%
CapEx/Depreciation snapshot only 0.147
Accruals Ratio 0.01 -0.01 -0.01 -0.03 -0.02 -0.01 -0.02 -0.02 -0.04 -0.04 -0.09 -0.10 -0.11 -0.11 -0.11 -0.09 -0.07 -0.03 -0.03 -0.04 -0.043
Sloan Accruals snapshot only 0.015
Cash Flow Adequacy snapshot only -10.833
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -5.0% -0.3% -0.2% -0.6% -0.8% -1.1% -0.7% -0.4% -0.3% -0.2% -0.2% -0.3% -0.0% -0.0% -0.0% -0.5% -0.4% -0.4% -1.2% -1.5% -1.50%
Total Shareholder Return -5.0% -0.3% -0.2% -0.6% -0.8% -1.1% -0.7% -0.4% -0.3% -0.2% -0.2% -0.3% -0.0% -0.0% -0.0% -0.5% -0.4% -0.4% -1.2% -1.5% -1.50%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 0.98 0.99 0.99 1.00 1.00 1.00 1.02 1.04 1.06 1.08 1.07 1.07 1.06 1.06 1.08 1.04 1.05 1.08 1.11 1.27 1.274
EBIT Margin -1.29 -1.30 -1.35 -1.49 -1.46 -1.32 -1.06 -1.02 -0.95 -1.01 -1.24 -1.16 -1.19 -1.04 -0.83 -0.72 -0.56 -0.29 -0.19 -0.13 -0.132
Asset Turnover 0.13 0.14 0.15 0.15 0.16 0.16 0.21 0.21 0.21 0.20 0.22 0.23 0.22 0.23 0.30 0.32 0.34 0.42 0.53 0.56 0.562
Equity Multiplier 1.54 1.54 1.51 1.51 1.51 1.51 1.67 1.67 1.67 1.67 1.96 1.96 1.96 1.96 2.35 2.35 2.35 2.35 2.50 2.50 2.496
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.22 $-1.35 $-1.47 $-1.62 $-1.63 $-1.55 $-1.40 $-1.36 $-1.32 $-1.35 $-1.55 $-1.48 $-1.45 $-1.32 $-1.08 $-0.95 $-0.80 $-0.49 $-0.39 $-0.32 $-0.32
Book Value/Share $5.30 $5.28 $4.28 $4.26 $4.24 $4.23 $3.24 $3.23 $3.21 $3.21 $2.13 $2.12 $2.09 $2.09 $1.38 $1.36 $1.33 $1.24 $1.43 $1.41 $1.44
Tangible Book/Share $4.37 $4.36 $3.37 $3.36 $3.35 $3.33 $2.37 $2.36 $2.34 $2.34 $1.27 $1.26 $1.25 $1.25 $0.55 $0.54 $0.53 $0.49 $0.64 $0.63 $0.63
Revenue/Share $0.95 $1.04 $1.09 $1.09 $1.12 $1.18 $1.30 $1.28 $1.31 $1.24 $1.18 $1.20 $1.14 $1.20 $1.22 $1.27 $1.35 $1.55 $1.81 $1.90 $1.90
FCF/Share $-1.67 $-1.71 $-1.80 $-1.75 $-1.69 $-1.61 $-1.40 $-1.36 $-1.18 $-1.18 $-1.15 $-0.99 $-0.93 $-0.78 $-0.67 $-0.59 $-0.54 $-0.39 $-0.32 $-0.19 $-0.19
OCF/Share $-1.30 $-1.27 $-1.36 $-1.40 $-1.47 $-1.45 $-1.29 $-1.24 $-1.07 $-1.10 $-1.08 $-0.93 $-0.88 $-0.74 $-0.65 $-0.57 $-0.53 $-0.37 $-0.30 $-0.17 $-0.17
Cash/Share $4.90 $4.89 $2.50 $2.49 $2.48 $2.47 $3.48 $3.47 $3.45 $3.44 $2.39 $2.38 $2.35 $2.35 $1.51 $1.49 $1.46 $1.36 $1.48 $1.46 $1.40
EBITDA/Share $-1.17 $-1.29 $-1.38 $-1.51 $-1.50 $-1.40 $-1.22 $-1.16 $-1.08 $-1.09 $-1.29 $-1.22 $-1.22 $-1.11 $-0.88 $-0.80 $-0.65 $-0.35 $-0.24 $-0.14 $-0.14
Debt/Share $0.77 $0.77 $0.79 $0.79 $0.78 $0.78 $0.75 $0.75 $0.75 $0.75 $0.68 $0.68 $0.67 $0.67 $0.61 $0.60 $0.59 $0.55 $1.83 $1.80 $1.80
Net Debt/Share $-4.14 $-4.12 $-1.71 $-1.70 $-1.70 $-1.69 $-2.73 $-2.72 $-2.70 $-2.70 $-1.71 $-1.70 $-1.68 $-1.68 $-0.90 $-0.89 $-0.87 $-0.81 $0.35 $0.34 $0.34
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 1.596
Altman Z-Prime snapshot only 1.389
Piotroski F-Score 2 3 2 2 2 3 4 4 4 4 2 3 2 3 4 4 4 4 5 5 5
Beneish M-Score -2.14 -2.43 -1.67 -1.76 -1.77 -1.76 -1.89 -1.42 -1.80 -1.20 -2.87 -3.09 -3.00 -3.15 -2.84 -2.77 -2.63 -2.05 -2.43 -2.55 -2.549
Ohlson O-Score snapshot only -6.226
ROIC (Greenblatt) snapshot only -13.67%
Net-Net WC snapshot only $0.08
EVA snapshot only $-64152450.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB-
Credit Score 74.02 73.71 74.12 56.54 47.63 37.88 37.82 37.57 37.15 31.65 31.83 32.00 31.70 31.86 30.99 30.79 30.60 41.41 45.85 37.86 37.857
Credit Grade snapshot only 13
Credit Trend snapshot only 7.072
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 31
Sector Credit Rank snapshot only 29

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms